Elevated Levels of Procoagulant Microvesicles and Tissue-Factor Bearing Microvesicles in Malaria Patients

Aymen M Madkhali1, Abdullah A Mobarki1, Ahmad H Ghzwani2

  • 1Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Gizan, Saudi Arabia.

Abstract

Insights

Malaria patients show significantly higher levels of procoagulant microvesicles (MVs) and tissue factor-bearing MVs. These elevated MV levels correlate with disease severity, suggesting their potential as biomarkers for malaria management.

Area of Science:

  • Hematology
  • Immunology
  • Pathology

Background:

  • Procoagulant microvesicles (MVs) are cell-derived fragments implicated in inflammation and thrombosis.
  • Tissue factor (TF) enhances MV procoagulant activity.
  • MVs and TF are linked to severe disease, including malaria.

Purpose of the Study:

  • To quantify circulating procoagulant MVs and TF-bearing MVs in malaria patients.
  • To correlate MV levels with hematological parameters and parasitemia.

Main Methods:

  • Plasma levels of MVs and TF-bearing MVs were measured in children and adults with Plasmodium falciparum infection.
  • Healthy controls were included for comparison.

Main Results:

  • Malaria patients exhibited significantly higher MVs (~3.8-fold) and TF-bearing MVs (~13.0-fold) compared to controls.
  • MVs showed an inverse correlation with platelet count, hemoglobin, and parasitemia.

Conclusions:

  • Elevated MVs and TF-bearing MVs may serve as valuable biomarkers for assessing procoagulant activity and inflammation in malaria.
  • These biomarkers can aid in evaluating disease severity and improving malaria management.